Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Corral

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
The Journal of Molecular Diagnostics : JMD|February 26, 2022
Molecular Dissection of Structural Variations Involved in Antithrombin DeficiencyBelén de la Morena-Barrio, Christelle Orlando, Alba Sanchis-Juan, et al.
Frontiers in Cardiovascular Medicine|August 8, 2022
Contact pathway in surgical and transcatheter aortic valve replacementMaría Eugenia de la Morena-Barrio, Javier Corral, Cecilia López-García, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2023
Targeted long-read sequencing identifies and characterizes structural variants in cases of inherited platelet disordersAna Zamora-Cánovas, Belén de la Morena-Barrio, Ana Marín-Quilez, et al.
American Journal of Hematology|July 29, 2021
High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: Description of a new syndromeMaría E de la Morena-Barrio, Réka Gindele, Carlos Bravo-Pérez, et al.
Haematologica|January 29, 2026
<i>De novo</i> mutations in antithrombin deficiency: high frequency and heterogeneous mechanismsPedro Garrido-Rodríguez, Belén De la Morena-Barrio, Carlos Bravo-Pérez, et al.
Vaccines|June 27, 2025
Target Trial Emulation of the Modified Vaccinia Ankara-Bavarian Nordic Vaccine for Pre-Exposure Mpox Prevention in At-Risk PopulationsClara Suñer, Roser Escrig-Sarreta, Cristina Galván-Casas, et al.
Frontiers in Immunology|June 29, 2026
Common and rare variants in complement genes as biomarkers of COVID-19 infection and severity. A lesson to learn for emerging pathogensMaría Eugenia De La Morena-Barrio, Ana Van Den Rym, Olga Escorial Sanz, et al.
The Lancet. Haematology|June 15, 2024
Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational studyCarlos Bravo-Pérez, Ana Blanco, Nuria Revilla, et al.
Experimental & Molecular Medicine|August 31, 2023
Scalable production of tissue-like vascularized liver organoids from human PSCsSean P Harrison, Richard Siller, Yoshiaki Tanaka, et al.
Journal of Inherited Metabolic Disease|February 12, 2019
International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow upRuqaiah Altassan, Romain Péanne, Jaak Jaeken, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
The Journal of Molecular Diagnostics : JMD|February 26, 2022
Molecular Dissection of Structural Variations Involved in Antithrombin DeficiencyBelén de la Morena-Barrio, Christelle Orlando, Alba Sanchis-Juan, et al.
Frontiers in Cardiovascular Medicine|August 8, 2022
Contact pathway in surgical and transcatheter aortic valve replacementMaría Eugenia de la Morena-Barrio, Javier Corral, Cecilia López-García, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2023
Targeted long-read sequencing identifies and characterizes structural variants in cases of inherited platelet disordersAna Zamora-Cánovas, Belén de la Morena-Barrio, Ana Marín-Quilez, et al.
American Journal of Hematology|July 29, 2021
High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: Description of a new syndromeMaría E de la Morena-Barrio, Réka Gindele, Carlos Bravo-Pérez, et al.
Haematologica|January 29, 2026
<i>De novo</i> mutations in antithrombin deficiency: high frequency and heterogeneous mechanismsPedro Garrido-Rodríguez, Belén De la Morena-Barrio, Carlos Bravo-Pérez, et al.
Vaccines|June 27, 2025
Target Trial Emulation of the Modified Vaccinia Ankara-Bavarian Nordic Vaccine for Pre-Exposure Mpox Prevention in At-Risk PopulationsClara Suñer, Roser Escrig-Sarreta, Cristina Galván-Casas, et al.
Frontiers in Immunology|June 29, 2026
Common and rare variants in complement genes as biomarkers of COVID-19 infection and severity. A lesson to learn for emerging pathogensMaría Eugenia De La Morena-Barrio, Ana Van Den Rym, Olga Escorial Sanz, et al.
The Lancet. Haematology|June 15, 2024
Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational studyCarlos Bravo-Pérez, Ana Blanco, Nuria Revilla, et al.
Experimental & Molecular Medicine|August 31, 2023
Scalable production of tissue-like vascularized liver organoids from human PSCsSean P Harrison, Richard Siller, Yoshiaki Tanaka, et al.
Journal of Inherited Metabolic Disease|February 12, 2019
International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow upRuqaiah Altassan, Romain Péanne, Jaak Jaeken, et al.
Pageof 20